Why is Transgene Biotek falling/rising?

As of 24-Jul, Transgene Biotek Ltd's stock price is currently at 4.80, reflecting a decrease of 0.06, or 1.23%. The stock has underperformed its sector by 2.18% today and has experienced a trend reversal, falling after two consecutive days of gains. Over the past week, the stock has declined by 4.76%, while it has shown a positive return of 9.59% over the past month. However, its year-to-date performance is notably poor, with a decline of 29.72%, and a significant drop of 51.32% over the past year. The stock is currently trading higher than its 50-day and 100-day moving averages but lower than its 5-day, 20-day, and 200-day moving averages. Additionally, there has been a rise in investor participation, with delivery volume increasing by 14.6% against the 5-day average, indicating some interest despite the overall decline.
In the broader market context, the Sensex has shown a slight decline of 0.09% over the past week, which suggests that the market is relatively stable compared to Transgene Biotek's significant drop. The stock's performance over the past year contrasts sharply with the benchmark, which has gained 2.54%, highlighting the challenges faced by Transgene Biotek in a generally positive market environment. The lack of available positive or negative factors further complicates the understanding of the stock's recent movement, as there are no specific catalysts identified that could explain the current downward trend.